{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:11:57Z","timestamp":1779120717097,"version":"3.51.4"},"reference-count":27,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"abstract":"\n Background & objectives:<\/jats:title>\n Certain antiepileptic drugs (AEDs) such as valproic acid (VPA) are known to affect body weight, and lipid profile. However, evidences regarding effects of AEDs on the body composition are deficient. This cross-sectional study compared the body composition and lipid profile among patients with epilepsy on newer and conventional AEDs.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n The patients with epilepsy (n=109) on treatment with conventional and newer AEDs (levetiracetam, lamotrigine and clobazam) for > 6 months were enrolled. Of these, 70 were on monotherapy: levetiracetam (n=12), VPA (n=16), carbamazepine (n=20) and phenytoin (n=22) and the remaining on polytherapy. Their body composition [body fat mass, lean dry mass (LDM), total body water (TBW), intracellular water (ICW), extracellular water (ECW) and basal metabolic rate (BMR) was estimated and biochemical parameters were assessed.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Levetiracetam group had no significant difference with VPA, carbamazepine, phenytoin and control groups, except low LDM (17.8\u00b12.4) than VPA groups (20.2\u00b12.7, P<\/jats:italic><0.05). In comparison with control, AEDs monotherapy groups had no significant difference, except higher LDM and ECW in VPA group. Among groups based on conventional and newer AEDs, there was no significant difference in body composition parameters except for higher LDM (as % of BW) in conventional AEDs only treated group than control (P<\/jats:italic><0.01).<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n The alterations observed in body composition with valproic acid in contrast to other AEDs like levetiracetam, carbamazepine and phenytoin could affect treatment response in epilepsy especially in subjects with already altered body composition status like obese and thin frail patients, which needs to be established by prospective studies (CTRI\/2013\/05\/003701).<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0971-5916.182623","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T12:53:28Z","timestamp":1464267208000},"page":"323-330","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs"],"prefix":"10.25259","volume":"143","author":[{"given":"Sudhir Chandra","family":"Sarangi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish Kumar","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogendra Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R2-12-20241212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5214\/ans.0972.7531.2006.130403","article-title":"Profile of pharmacotherapy and pharmacoeconomics of epilepsy treatment at a tertiary care hospital","volume":"13","author":"Sigamani","year":"2006","journal-title":"Ann Neurosci"},{"key":"R3-12-20241212","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-3-642-24716-3_20","article-title":"Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide","volume":"209","author":"Antel","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"R4-12-20241212","first-page":"216","article-title":"Insulin resistance in epileptic patients during treatment of valproic acid","volume":"33","author":"Ding","year":"2004","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"R5-12-20241212","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1528-1167.2008.01676.x","article-title":"Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study","volume":"49","author":"Sahota","year":"2008","journal-title":"Epilepsia"},{"key":"R6-12-20241212","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1079\/BJN2001470","article-title":"Contribution of body composition to nutritional assessment at hospital admission in 995 patients: a controlled population study","volume":"86","author":"Kyle","year":"2001","journal-title":"Br J Nutr"},{"key":"R7-12-20241212","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000324111","article-title":"Assessment of body composition in peritoneal dialysis patients using bioelectrical impedance and dual-energy X-ray absorptiometry","volume":"33","author":"F\u00fcrstenberg","year":"2011","journal-title":"Am J Nephrol"},{"key":"R8-12-20241212","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp.2010.211474","article-title":"Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients","volume":"82","author":"Marin","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-12-20241212","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.seizure.2012.06.001","article-title":"Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate","volume":"21","author":"Fang","year":"2012","journal-title":"Seizure"},{"key":"R10-12-20241212","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eplepsyres.2009.04.005","article-title":"The effect of carbamazepine treatment on serum leptin levels","volume":"86","author":"Uludag","year":"2009","journal-title":"Epilepsy Res"},{"key":"R11-12-20241212","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann Neurol"},{"key":"R12-12-20241212","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/sj.ijo.0802167","article-title":"Body composition estimates from NHANES III bioelectrical impedance data","volume":"26","author":"Chumlea","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R13-12-20241212","first-page":"611","article-title":"Techniques for the measurement of body composition: a practical guide","volume":"17","author":"Jebb","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R14-12-20241212","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ajcn\/40.1.168","article-title":"The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass","volume":"40","author":"Roza","year":"1984","journal-title":"Am J Clin Nutr"},{"key":"R15-12-20241212","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/0972-2327.94992","article-title":"Obesity, polycystic ovarian syndrome and thyroid dysfunction in women with epilepsy","volume":"15","author":"Ayyagari","year":"2012","journal-title":"Ann Indian Acad Neurol"},{"key":"R16-12-20241212","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.clnu.2007.08.002","article-title":"The economic impact of disease-related malnutrition at hospital admission","volume":"26","author":"Amaral","year":"2007","journal-title":"Clin Nutr"},{"key":"R17-12-20241212","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","article-title":"A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis","volume":"58","author":"Freitag","year":"2002","journal-title":"Neurology"},{"key":"R18-12-20241212","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01204.x","article-title":"Weight gain in bipolar disorder: pharmacological treatment as a contributing factor","volume":"118","author":"Torrent","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R19-12-20241212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpn.2008.05.005","article-title":"States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain","volume":"13","author":"Hamed","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"R20-12-20241212","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1080\/00207450290026148","article-title":"Does long-term use of valproate cause weight gain in prepubertal epileptic children?","volume":"112","author":"Caksen","year":"2002","journal-title":"Int J Neurosci"},{"key":"R21-12-20241212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2008.05.006","article-title":"Lack of valproic acid-associated weight gain in prepubertal children","volume":"39","author":"Espinosa","year":"2008","journal-title":"Pediatr Neurol"},{"key":"R22-12-20241212","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy - a review","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"R23-12-20241212","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/bmj.327.7420.905","article-title":"Drug points: Weight loss associated with levetiracetam","volume":"327","author":"Hadjikoutis","year":"2003","journal-title":"BMJ"},{"key":"R24-12-20241212","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1528-1167.2007.01273.x","article-title":"Dramatic weight loss with levetiracetam","volume":"49","author":"Gelisse","year":"2008","journal-title":"Epilepsia"},{"key":"R25-12-20241212","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eplepsyres.2008.03.017","article-title":"Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children","volume":"80","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsy Res"},{"key":"R26-12-20241212","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1528-1167.2006.00953.x","article-title":"Endocrine effects of valproate in adolescent girls with epilepsy","volume":"48","author":"de Vries","year":"2007","journal-title":"Epilepsia"},{"key":"R27-12-20241212","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2010.01372.x","article-title":"Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine","volume":"122","author":"Svalheim","year":"2010","journal-title":"Acta Neurol Scand Suppl"},{"key":"R28-12-20241212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01806671","article-title":"Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes","volume":"38","author":"Cornish","year":"1996","journal-title":"Breast Cancer Res Treat"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201643030-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:57:18Z","timestamp":1751497038000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/comparison-of-body-composition-in-persons-with-epilepsy-on-conventional-new-antiepileptic-drugs\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0971-5916.182623","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}